Latest Remote magnetic navigation Stories
12-month Clinical Trial Met Primary Safety and Efficacy Endpoints MARLBOROUGH, Mass., May 15, 2015 /PRNewswire/ -- CardioFocus, Inc., a medical device company developing the HeartLight®
Key Late-Breaking and Principal Investigators' Oral Theatre Presentations on Friday, May 15 MARLBOROUGH, Mass., April 28, 2015 /PRNewswire/ -- CardioFocus, Inc., a medical device
SALT LAKE CITY, Sept.
Updated Guidelines and Launch of Contact Force-Sensing Catheters Will Drive Continued Interest in Treating Atrial Fibrillation, According to Findings from Decision Resources Group BURLINGTON,
Complication Rates of Atrial Fibrillation Ablation was presented at QCOR 2014 Scientific Sessions BOWIE, Md., June 5, 2014 /PRNewswire/ -- Inovalon, Inc., a leading technology company
Presentations at Stanford Biodesign New Arrhythmia Technologies Retreat and Heart Rhythm Society (HRS) Continue Focus on Atrial Fibrillation Ablation MARLBOROUGH, Mass., May 5, 2014 /PRNewswire/
LONDON, April 28, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
Presentations to Review Findings from Leading Cardiologists MARLBOROUGH, Mass., April 21, 2014 /PRNewswire/ -- CardioFocus, Inc., developer of the HeartLight® Endoscopic Ablation
- Led by New Enterprise Associates and Experienced Medical Device Industry Veterans, Financing Will Support Development of Next Generation TempaSure(TM) Radiometric Temperature-Sensing Radio-Frequency
Texas Cardiac Arrhythmia Institute at St.